Minocycline

Perflubutane Minocycline can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy. Effects on nitric oxide synthases". Minocycline has been shown to reduce the risk of the honey trap effect in healthy human subjects. Clozapine Minocycline may increase the central nervous system depressant CNS depressant activities of Clozapine. Bromisoval Minocycline may increase the central nervous system depressant CNS depressant activities of Bromisoval. Olopatadine Minocycline may increase the central nervous system depressant CNS depressant activities of Olopatadine. Gestrinone The serum concentration of Gestrinone can be decreased when it is combined with Minocycline. Retrieved 7 August Some women who take minocycline develop vaginal yeast infections. Asenapine Minocycline may increase the central nervous system depressant CNS depressant activities of Asenapine. Current research is examining the minocin neuroprotective effects of minocycline against progression of Huntington's Disease, an inherited neurodegenerative disorder. Ionotropic glutamate receptor modulators. Minocycline and doxycycline are frequently used for the treatment of acne vulgaris, minocin. Methylpentynol Minocycline may increase the central nervous system depressant CNS depressant activities of Methylpentynol. Nitrazepam Minocycline may increase the central nervous system depressant CNS depressant activities of Nitrazepam. Pyrithyldione Minocycline may increase the central nervous system depressant CNS depressant activities of Pyrithyldione. This effect is mediated by a direct action of minocycline on the activated T cells and on microgliawhich results in the decreased ability of T cells to contact microglia, which impairs cytokine production in T cell-microglia signal transduction. Isoflurane Minocycline may increase the central nervous system depressant CNS depressant activities of Isoflurane. Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocin is combined with Rosuvastatin. Magaldrate Magaldrate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Perospirone Minocycline may increase the central nervous system depressant CNS depressant activities of Perospirone. Butethal Minocycline may increase the central nervous system depressant CNS depressant activities of Butethal. Ramelteon Minocycline may increase the central nervous system depressant CNS depressant activities of Ramelteon. Medetomidine Minocycline may increase the central nervous system depressant CNS depressant activities of Medetomidine.

Lamotrigine Minocycline may increase the central nervous system depressant CNS depressant activities of Lamotrigine. Hydroxyzine Minocycline may increase the central nervous system depressant CNS depressant activities of Hydroxyzine. Oxitriptan Minocycline may increase the central nervous system depressant CNS depressant activities of Oxitriptan. Tramiprosate Minocycline may increase the central nervous system depressant CNS depressant activities of Tramiprosate. Minocycline, like most tetracyclines, becomes dangerous past its expiration date, minocin. Proxibarbal Minocycline may increase the central nervous system depressant CNS depressant activities of Proxibarbal. Ipecac The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Ipecac. Sisomicin The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Sisomicin. Ferumoxsil Minocycline can cause a decrease in the absorption of Ferumoxsil resulting in a reduced serum concentration and potentially a decrease in efficacy. Colchicine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Colchicine. Ferrous sulfate anhydrous Minocycline can cause a decrease in the absorption of Ferrous sulfate anhydrous resulting in a reduced serum concentration and potentially a decrease in efficacy. Remacemide Minocycline may increase the central nervous system depressant CNS depressant activities of Remacemide. Chlordiazepoxide Minocycline may increase the central nervous system depressant CNS depressant activities of Chlordiazepoxide. Lanthanum carbonate The serum concentration of Minocycline can be decreased when it is combined with Lanthanum carbonate. Octylphenoxy polyethoxyethanol The serum concentration of Octylphenoxy polyethoxyethanol can be decreased when it is combined with Minocycline. Ecopipam Minocycline may increase the central nervous system depressant CNS depressant activities of Ecopipam. Early research has found a tentative benefit from minocycline in schizophrenia, [71] with several trials underway. Dantrolene Minocycline may increase the central nervous system depressant CNS depressant activities of Dantrolene. Minocycline, but not other tetracyclines, can cause vestibular disturbances with minocin, ataxiaminocin, and tinnitus. These effects are thought to be related to minocycline's greater penetration into the central nervous system. Pimavanserin Minocycline may increase the central nervous system depressant CNS depressant activities of Pimavanserin. Prazepam Minocycline may increase the central nervous system depressant CNS depressant activities of Prazepam. Lincomycin The risk or severity of minocin blockade can be increased when Minocycline is combined with Lincomycin, minocin. Nitrous oxide Minocycline may increase the central nervous system depressant CNS depressant activities of Nitrous oxide.

Pharmacology

Eslicarbazepine Minocycline may increase the central nervous system depressant CNS depressant activities of Eslicarbazepine. Journal of Medical Case Reports. Methylestrenolone The serum concentration of Methylestrenolone can be decreased when it is combined with Minocycline. Levocabastine Minocycline may increase the central nervous system depressant CNS depressant activities of Minodin. Metildigoxin Minocycline can cause an increase in the absorption of Metildigoxin resulting in an increased serum concentration and potentially a worsening of adverse effects. Melperone Minocycline may increase the central nervous system depressant CNS depressant activities of Melperone. Tacrolimus The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrolimus is combined with Minocin. Levocarnitine The excretion of Levocarnitine can be decreased when combined minocin Minocycline. In November a report "Translation attenuation by minocycline minocij longevity minocin proteostasis in old post-stress-responsive organisms" [75] by Scrips researchers indicates other possible uses for minocycline in protean aggregation disorders. Etofibrate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Etofibrate. Monitor blood, renal, and hepatic function periodically. Penimepicycline The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Minoxin. Etonogestrel The serum concentration of Etonogestrel can be decreased when it is combined with Minocycline. Avoid sun or UV light. Diphenhydramine Minocycline may increase the central nervous system depressant CNS depressant activities of Diphenhydramine. Oxycodone Minocycline may increase the central nervous system depressant CNS depressant activities of Oxycodone. Carbenicillin The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Minocycline. Iron Minocycline can cause a decrease in the absorption of Iron resulting in a minocin serum concentration and potentially a decrease in efficacy. Chlormezanone Minocycline may increase the central nervous system depressant CNS depressant activities of Chlormezanone, minocin.

Cholestyramine Cholestyramine imnocin cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Meclizine Minocycline may increase the central nervous system depressant CNS depressant activities of Meclizine. Eltanolone Minocycline may increase the central nervous system depressant CNS depressant activities of Eltanolone. Barbital Minocycline may increase the central nervous system depressant CNS depressant activities of Barbital. Chloramphenicol Azidamfenicol Thiamphenicol Florfenicol. Magnesium acetate The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Magnesium acetate. Etofibrate The risk or severity of myopathy, minocin, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Etofibrate. As a result of its long half-life, it generally has serum levels minocin to four times that of minocin simple water-soluble tetracyclines. Acepromazine Minocycline may increase the central nervous system depressant CNS depressant activities of Acepromazine. Framycetin The risk or severity of neuromuscular mimocin can be increased when Framycetin is combined with Minocycline. Iron saccharate The minocin concentration of Minocycline can be decreased when it is combined with Iron saccharate. Bufotenine Minocycline may increase the central nervous system mlnocin CNS minocin activities of Bufotenine. Fludiazepam Minocycline may increase the central nervous system minoin CNS depressant activities of Fludiazepam. Ketazolam Minocycline may increase minocin central nervous system minoocin CNS depressant activities of Ketazolam. Fexofenadine Minocycline may increase the central nervous system depressant CNS depressant activities of Fexofenadine. Magnesium lactate Magnesium lactate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in ninocin. Eszopiclone Minocycline may increase the central nervous minocin minocni CNS depressant activities of Eszopiclone. Cloxazolam Minocycline may increase the central nervous system depressant CNS minocin activities of Cloxazolam. Hypericin Minocycline may increase the central nervous system depressant CNS depressant activities of Hypericin. Levels of interleukin ILwhich at high levels might antagonize the proinflammatory IL receptor, were elevated over 18 months of treatment, as were levels of soluble vascular cell adhesion molecule-1 VCAM Paromomycin The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Paromomycin. Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can minocin increased when Isoniazid is combined with Minocycline. Norethynodrel The serum minockn of Norethynodrel can be decreased when it is combined with Minocycline. Alendronic acid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Minocycline. Calcium polycarbophil The serum concentration of Minocin can be decreased when it is combined with Calcium polycarbophil.

Minocin

Perazine Minocycline may increase the central nervous system depressant CNS depressant activities of Perazine. It minocin be used to treat certain strains of methicillin-resistant S. Penimepicycline The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Penimepicycline. TG The therapeutic efficacy of TG can be decreased when used in combination with Minocycline. Dexamethasone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocin is combined with Dexamethasone. Dixyrazine Minocycline may increase the central nervous system depressant Minocin depressant activities of Dixyrazine. European Archives of Psychiatry and Clinical Neuroscience. Avoid minocin penicillins, mlnocin. Pemetrexed The excretion of Pemetrexed can be decreased when combined with Minocycline. Risperidone Minocycline may increase the central nervous system depressant CNS depressant jinocin of Risperidone. Some women who take minocycline develop vaginal yeast infections. Brexpiprazole Minocycline may increase the central nervous system depressant CNS depressant activities of Brexpiprazole. Haloperidol Minocycline may increase the central nervous system depressant CNS depressant activities of Haloperidol. Levocabastine Minocycline may increase the central nervous system depressant CNS minoci activities of Levocabastine, minocin. Etacrynic acid The mibocin or severity of neuromuscular blockade can be increased when Munocin acid is combined with Minocycline. Esmirtazapine Minocycline may increase the central nervous system depressant CNS depressant activities of Esmirtazapine. Methapyrilene Minocycline may increase the central nervous system depressant CNS depressant activities of Methapyrilene. Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Minocycline. Emepronium Minocycline may increase the central nervous system depressant CNS depressant activities of Emepronium, minocin.

Pamidronic acid The risk minocin severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Minocycline. Tazobactam The therapeutic efficacy of Tazobactam can be decreased when used in combination with Minocycline. Desflurane Minocycline may increase the central nervous system depressant CNS depressant activities of Desflurane. Calcium cation The serum concentration of Minocycline can be decreased when it is combined with Calcium cation. Lercanidipine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Minocycline, minocin. May interfere with fluorescence test. Minocycline is the most lipid-soluble of the minocin antibiotics, giving it the greatest penetration into the prostate and brain, but also the greatest amount of central nervous system -related side effects, such as vertigo. Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Minocycline. Meptazinol Minocycline may increase the central nervous system depressant CNS depressant activities of Meptazinol. Retrieved 7 August Tetraferric tricitrate decahydrate Minocycline can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy. Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Minocycline. Perospirone Minocycline may increase the central nervous system depressant CNS depressant activities of Perospirone. Psilocybine Minocycline may increase the central nervous system depressant CNS depressant activities of Psilocybine. Clemastine Minocycline may increase the central nervous system depressant CNS depressant activities of Clemastine. Chlorzoxazone Minocycline may increase the central nervous system depressant CNS depressant activities of Chlorzoxazone. Alimemazine Minocycline may increase the central nervous system depressant CNS depressant activities minocin Alimemazine. Alprostadil The excretion of Alprostadil can be decreased when combined with Minocycline. Gentamicin C1a The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Gentamicin C1a.

Identification

Minocin hydroxide Magnesium hydroxide can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Thiopropazate Minocycline may increase the central nervous system depressant CNS depressant activities of Thiopropazate. Fencamfamine Minocycline may increase the central nervous system depressant CNS depressant activities of Fencamfamine. Hypericin Minocycline may increase the central nervous system depressant CNS depressant activities of Hypericin. Sodium Citrate The therapeutic efficacy of Minocycline can be decreased when used in combination with Sodium Citrate. Cinazepam Minocycline may increase the central nervous system depressant CNS depressant activities of Cinazepam. Magnesium Aluminum Silicate The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Magnesium Aluminum Silicate. Phenprobamate Minocycline may increase the central nervous system depressant CNS depressant activities of Phenprobamate. Felbamate Minocycline may increase the central nervous system depressant CNS depressant activities of Felbamate. Rufinamide Minocycline may increase the central nervous system depressant CNS depressant activities of Rufinamide, minocin. It cites a potential link between the use of minocycline products and autoimmune disease in pediatric patients. A randomised double-blind placebo-controlled clinical trial in patients on standard treatment". Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Raltegravir. NMDA receptor antagonists induce cortical apoptosis in perinatal rodents and sustain schizophrenia-like alterations that are ameliorated by treatment with antipsychotics. Methotrimeprazine Minocycline may increase the central nervous system minocim CNS depressant activities of Methotrimeprazine. Dihydroetorphine Minocycline may increase the central nervous system depressant CNS depressant activities of Minocin. Minoocin College of Rheumatology. Flunitrazepam Minocycline may increase the central nervous system depressant CNS depressant activities of Flunitrazepam. Rindopepimut The mlnocin efficacy of Rindopepimut can be decreased when used in combination with Minocycline. Carbimazole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Minocycline. Azelastine Minocycline may increase the central nervous system depressant CNS depressant activities of Azelastine. Minocin adenovirus e minocin 4 strain cl antigen The therapeutic efficacy of Human adenovirus e serotype 4 strain cl antigen can be decreased when used minocin combination with Minocycline. Mibocin and MRI outcomes in this study were supported by systemic immunological changes and call for further investigation of minocycline in MS. Dibekacin The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Dibekacin. Minocycline and doxycycline are frequently used for the treatment of acne vulgaris.

Propicillin The therapeutic efficacy of Propicillin can be decreased when used in combination with Minocycline. Cefotiam The excretion of Cefotiam can be decreased when combined with Minocycline. Clothiapine Minocycline may increase the central nervous system depressant CNS depressant activities of Clothiapine. Aluminium glycinate Aluminium glycinate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Minocycline as HCl 50mg, mg; pellet-filled caps. Do you need help? Pentolinium The risk or severity of adverse effects can be increased when Minocycline is combined with Pentolinium. Doxylamine Minocycline may increase the central nervous system depressant CNS depressant activities of Doxylamine. Meprobamate Minocycline may increase the central nervous system depressant CNS depressant activities of Meprobamate. Retrieved 13 May Indometacin The excretion of Indometacin can be decreased when combined with Minocycline. Oseltamivir The excretion of Oseltamivir can be decreased when combined with Minocycline. Carfentanil Minocycline may increase the central nervous system depressant CNS depressant activities of Carfentanil. Unlike some of the other tetracycline group antibiotics, it can be taken with calcium-rich foods such as milk, although this does reduce the absorption slightly. Clobazam Minocycline may increase the central nervous system depressant CNS depressant activities of Clobazam. Tofisopam Minocycline may increase the central nervous system depressant CNS depressant activities of Tofisopam. Hexobarbital Minocycline may increase the central nervous system depressant CNS depressant activities of Hexobarbital. Leuprolide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Minocycline. Acetyldigoxin Minocycline can cause an increase in the absorption of Acetyldigoxin resulting in an increased serum concentration and potentially a worsening of adverse effects. Pamidronic acid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Minocycline. Levacetylmethadol Minocycline may increase the central nervous system depressant CNS depressant activities of Levacetylmethadol.

Generic Name and Formulations:

Tetrodotoxin Minocycline may increase the central nervous system depressant CNS depressant activities of Tetrodotoxin. Minocycline is the most lipid-soluble of the tetracycline-class antibiotics, giving it the greatest penetration into the prostate and brain, but also the greatest amount of central nervous system -related side effects, such as vertigo. Sevelamer Sevelamer can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Minocycline. Bausch Health Companies Inc. Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Rosuvastatin. Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Pitavastatin. Pantoprazole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pantoprazole is combined with Minocycline. Drug Interactions in Infectious Diseases. Fluphenazine Minocycline may increase the central nervous system depressant CNS depressant activities of Fluphenazine. Ethinylestradiol The serum concentration of Ethinylestradiol can be decreased when it is combined with Minocycline. Eluxadoline The excretion of Eluxadoline can be decreased when combined with Minocycline. Fenretinide The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Fenretinide is combined with Minocycline. Fexofenadine Minocycline may increase the central nervous system depressant CNS depressant activities of Fexofenadine. Rotavirus Vaccine The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Minocycline. Efavirenz Minocycline may increase the central nervous system depressant CNS depressant activities of Efavirenz. Magnesium glycinate The risk or severity of neuromuscular blockade can be increased when Minocycline is combined with Magnesium glycinate. Paclitaxel The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Paclitaxel. Carindacillin The therapeutic efficacy of Carindacillin can be decreased when used in combination with Minocycline. Lofentanil Minocycline may increase the central nervous system depressant CNS depressant activities of Lofentanil. Glutethimide Minocycline may increase the central nervous system depressant CNS depressant activities of Glutethimide.

minocin

Hexobarbital Minocycline may increase the central nervous system depressant CNS depressant activities of Hexobarbital. Atracurium Minocycline may increase the central nervous system depressant CNS depressant activities of Atracurium. Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Minocycline. Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Rosuvastatin. Eluxadoline The excretion of Eluxadoline can be decreased when combined with Minocycline. Acne -treating agents D Metampicillin The therapeutic efficacy of Metampicillin can be decreased when used in combination with Minocycline. Minocycline is passed into breast milk, so mothers should avoid breast-feeding in order to prevent delayed development of teeth and bones in their infants. Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Minocycline. Phenoperidine Minocycline may increase the central nervous system depressant CNS depressant activities of Phenoperidine. Uncomplicated urethral, endocervical, or rectal infection w. Baricitinib The excretion of Baricitinib can be decreased when combined with Minocycline. Demeclocycline The risk or severity of neuromuscular blockade can be increased when Demeclocycline is combined with Minocycline. Epicillin The therapeutic efficacy of Epicillin can be decreased when used in combination with Minocycline. Pimozide Minocycline may increase the central nervous system depressant CNS depressant activities of Pimozide. Oxprenolol Minocycline may increase the central nervous system depressant CNS depressant activities of Oxprenolol. Leuprolide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Minocycline. Almasilate Almasilate can cause minoxin decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. Occasionally, minocin, minocycline therapy may result in autoimmune disorders such as drug-related lupus and minocin hepatitis, which usually occurs in men who also developed minocycline-induced lupus; however, women are more likely to develop minocycline-induced lupus. Emepronium Minocycline may increase the central nervous mincoin depressant CNS depressant activities of Emepronium. Pipotiazine Minocycline may increase the central nervous system depressant CNS depressant activities of Pipotiazine. Digoxin Minocycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and minocin a worsening of adverse effects. Colestipol Colestipol can cause a decrease in the absorption of Minocycline resulting minocin a reduced serum concentration and potentially a minnocin in efficacy.

Enflurane Minocycline may increase the central nervous system depressant CNS depressant activities of Enflurane. Alcuronium Minocycline may increase the central nervous system depressant CNS depressant activities of Alcuronium. Pentazocine Minocycline may increase the central nervous system depressant CNS depressant activities of Pentazocine. Ferric oxyhydroxide Minocycline can cause a decrease in the absorption of Ferric oxyhydroxide resulting in a reduced serum concentration and potentially a decrease in efficacy. Barbital Minocycline may increase the central nervous system depressant CNS depressant activities of Barbital. Mivacurium Minocycline may increase the central nervous system depressant CNS depressant activities of Mivacurium. Imagabalin Minocycline may increase the central nervous system depressant CNS depressant activities of Imagabalin. Medazepam Minocycline may increase the central nervous system depressant CNS depressant activities of Medazepam. Somatotropin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline. Diethyl ether Minocycline may increase the central nervous system depressant CNS depressant activities of Diethyl ether. American College of Rheumatology. Dinoprostone The excretion of Dinoprostone can be decreased when combined with Minocycline. Styramate Minocycline may increase the central nervous system depressant CNS depressant activities of Styramate. Clonidine Minocycline may increase the central nervous system depressant CNS depressant activities of Clonidine. Oxymorphone Minocycline may increase the central nervous system depressant CNS depressant activities of Oxymorphone. Ethchlorvynol Minocycline may increase the central nervous system depressant CNS depressant activities of Ethchlorvynol. Calcium pangamate The serum concentration of Minocycline can be decreased when it is combined with Calcium pangamate. Metampicillin The minocin efficacy of Metampicillin can be decreased when used in combination with Minocycline. Minocycline is passed munocin breast milk, so mothers should avoid breast-feeding in order to prevent delayed development minocin teeth and bones in their infants. Aceprometazine Minocycline may increase the central nervous system depressant CNS depressant activities of Aceprometazine.